Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13

1.

Should blood be an essential medicine?

Klein HG.

N Engl J Med. 2013 Jan 17;368(3):199-201. doi: 10.1056/NEJMp1213134. No abstract available.

2.
3.

Ex-vivo red blood cells generation: a step ahead in transfusion medicine?

Lippi G, Montagnana M, Franchini M.

Eur J Intern Med. 2011 Feb;22(1):16-9. doi: 10.1016/j.ejim.2010.08.001. Epub 2010 Aug 30. Review.

PMID:
21238887
4.

Current issues in transfusion medicine in Norway.

Flesland O, Seghatchian J.

Transfus Apher Sci. 2005 Feb;32(1):7-10. Epub 2005 Jan 4. Review.

PMID:
15737866
5.

Regulatory issues in CAM.

Parkman CA.

Case Manager. 2004 Nov-Dec;15(6):26-9. Review. No abstract available.

PMID:
15557988
6.

The regulatory pendulum in transfusion medicine.

Farrugia A.

Transfus Med Rev. 2002 Oct;16(4):273-82. Review.

PMID:
12415513
7.

The impact of states' small group health insurance reforms on uninsurance rates.

Xirasagar S, Stoskopf CH, Hussey JR, Samuels ME, Shrader WR, Saunders RP.

J Health Soc Policy. 2005;20(3):11-50. Review.

PMID:
16236677
8.

Role of regulatory agencies.

Epstein J, Seitz R, Dhingra N, Ganz PR, Gharehbaghian A, Spindel R, Teo D, Reddy R.

Biologicals. 2009 Apr;37(2):94-102. doi: 10.1016/j.biologicals.2009.01.004. Epub 2009 Feb 20. Review.

PMID:
19230707
9.

Proteomic applications in blood transfusion: working the jigsaw puzzle.

Devine DV, Schubert P.

Vox Sang. 2011 Jan;100(1):84-91. doi: 10.1111/j.1423-0410.2010.01433.x. Review.

PMID:
21175658
10.

[Progress and problems in transfusion medicine].

Ohto H.

Rinsho Ketsueki. 2011 Oct;52(10):1544-9. Review. Japanese. No abstract available.

PMID:
21971231
11.

Proteomics and transfusion medicine: future perspectives.

Queloz PA, Thadikkaran L, Crettaz D, Rossier JS, Barelli S, Tissot JD.

Proteomics. 2006 Oct;6(20):5605-14. Review.

PMID:
16972297
12.
13.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk